Editorial Board
Editor-in-Chief
Prof. Dr. Antonino Carbone
Affiliation Centro di Riferimento Oncologico, Aviano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Aviano, Italy.
Research Interests: hematopathology; Hodgkin lymphoma; non Hodgkin lymphoma; HIV-associated lymphoma; virus-associated lymphoma; post-transplant lymphoma; pathology; immunohistochemistry; tumour microenvironment; telepathology.
Associate Editors-in-Chief
Prof. Dr. Riccardo Dolcetti
Sir Peter MacCallum Cancer Centre, Department of Oncology, University of Melbourne, Melbourne, Australia.
Research Interests: breast; head and neck; melanoma skin; neuro-oncology.
Prof. Dr. Johannes Haybaeck
Diagnostic and Research Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.
Research Interests: eukaryotic translation initiation factors; novel biomarkers for oncologic and inflammation diseases; cancer biology; degenerative diseases.
Editorial Board Members
Prof. Dr. Angelo Paolo Dei Tos
School of Medicine, University of Padua, Padua, Italy.
Research Interests: soft-tissue and tumour pathology; oncological pathology.
Prof. Dr. Umberto Gianelli
Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milano, Italy.
Research Interests: hematopathology; leukemia; lymphoma; histopathology; microscopy; surgical pathology; pathology; clinical hematology; immunohistochemistry; chemotherapy; cell biology.
Dr. Gautam Sethi
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
Research Interests: cancer; inflammation; transcription factors; vitamin; apoptosis.
Prof. Dr. Undurti N. Das
UND Life Sciences, 2221 NW 5th St, Battle Ground, WA 98604, USA.
Research Interests: bioactive lipids; essential fatty acids; polyunsaturated fatty acids; prostaglandins; lipoxins; resolvins; protectins and maresins; reactive oxygen species; lipid peroxidation; cancer; rheumatology; inflammation; immune response; immune checkpoint inhibitors; lupus; radiation induced injury; diabetes mellitus; insulin resistance.
Dr. Annunziata Gloghini
Dipartimento Servizi e Diagnostica Avanzata, Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Research Interests: immunohistochemistry; in situ molecular techniques; brightfield in situ hybridization; virologic characterization; EBV; HHV8/KSHV; HPV; tumor microenvironment; Hodgkin’s lymphoma; HIV-associated lymphomas.
Prof. Dr. Gabriel Lopez-Berestein
Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Research Interests: small interfering RNA; experimental therapeutics; cancer; apoptosis.
Dr. Oliver Kepp
Faculty of Medicine, University of Paris Sud, 94270 Kremlin-Bicêtre, France.
Research Interests: cancer; immunology; cell death; apoptosis; autophagy.
Prof. Dr. Blossom Damania
Boshamer Distinguished Professor, Vice Dean for Research, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Research Interests: oncogenic human viruses and host-pathogen interactions.
Prof. Dr. Chiara Costanza Volpi
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Istituto Tumori di Milano, Dipartimento di Patologia Diagnostica e Laboratorio, Milan, Italy.
Research Interests: cancer biology; cell signaling; signaling pathways; breast cancer; cell culture; immunohistochemistry; in situ hybridization; oral; head and neck cancer; mRNA expression; human papillomavirus (HPV).
